Literature DB >> 24344253

Determinants of Survival in Adult HIV Clients on Antiretroviral Therapy in Lawra and Jirapa Districts of Upper West Region, Ghana.

Gabriel Asare Okyere1, Paul Awinbil Alalbil2, Henry Ping-Naah2, Yakubu Tifere2.   

Abstract

We describe the rate of death and identify the determinants of survival in a cohort of adults starting antiretroviral therapy (ART) in 2 hospitals in Upper West Region, Ghana. Kaplan-Meier model was used to estimate the survival probability after ART initiation and Cox proportional hazard model used to assess the relationship between baseline variables and mortality. A total of 91 clients who were initiated on ART in both hospitals participated in the study. Clients staged in the World Health Organization (WHO) clinical stage III/IV had a higher risk of mortality than those staging I/II (hazard ratio [HR] of 3.93). Hemoglobin value at baseline with a cutoff ≥12 g/dL for women (and ≥13 for men) was strongly associated with mortality in participants with an HR of 3.87 (95% confidence interval [CI]: 0.71-21.19) for severe anemia, 2.11 (95% CI: 0.45-9.93) for moderate anemia, and 0.88 (95% CI: 0.16-4.82) for mild anemia. Anemia and WHO staging were independent predictors of mortality.
© The Author(s) 2013.

Entities:  

Keywords:  AIDS; Cox proportional hazard; HIV; Kaplan-Meier; survival function

Mesh:

Substances:

Year:  2013        PMID: 24344253     DOI: 10.1177/2325957413500531

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  2 in total

Review 1.  Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013.

Authors:  Matthew P Fox; Sydney Rosen
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

2.  Epidemiology of survival pattern and its predictors among HIV positive patients on highly active antiretroviral therapy in Southern Ethiopia public health facilities: a retrospective cohort study.

Authors:  Abewa Kebede; Fasil Tessema; Gadisa Bekele; Zerihun Kura; Hailu Merga
Journal:  AIDS Res Ther       Date:  2020-08-05       Impact factor: 2.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.